About this episode
We demystify primary aldosteronism, MRAs (mineralocorticoid receptor antagonists), non-steroidal MRAs, and how to recognize and treat renovascular hypertension with nephrologist/hypertension expert, Dr. Matt Luther (
@DrJMLuther) as part of the NephMadness PodCrawl 2023.
Fill out a bracket for NephMadness and check out all eight NephMadness PodCrawl participants at
NephMadness.com/podcrawl (list below) and the
MRA region write-up by Micah Schub (
@AcidBassMD).
-
The Curbsiders gets the skinny on mineralocorticoid receptor antagonists
-
Core IM will be covering Kidney Transplant in their classic Five Pearl format
-
The CardioNerds will be covering the effect of Heart Failure Devices on Kidney Health
-
Freely Filtered will try to understand thrombotic microangiopathy
-
ISN Global Kidney Care goes deep on IgA nephropathy
-
The Cribsiders look at transitions, first the Pediatrics to Adult nephrology transition and then from living to death with palliative nephrology
-
Fellow on Call will be covering Onconephrology
- And finally, The Nephron Segment looks at Transgender Health and CKD
- Intro
- Diagnosis and Management of Primary Aldosteronism (PA)
- MRAs vs non-steroidal MRAs (mineralocorticoid receptor antagonists)
- NephMadness MRA region picks
- Renovascular Hypertension
- Outro
Credits
- Writer and Producer: Matthew Watto MD
- Show Notes: Matthew Watto MD
- Cover Art & Infographic: Matthew Watto MD
- Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Reviewer: Leah Witt MD
- Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Technical Production: PodPaste
- Guest: J. Matthew Luther MD
Today
#496 Hotcakes: Cannabidiol (CBD)-induced liver injury, IV iron for HFrEF, bedtime BP meds, Carpal Tunnel Syndrome & RA, & Finerenone for HFpEF
Join us as we review recent practice-changing articles on cannabidiol (CBD)-induced liver injury, IV iron for HFrEF, bedtime administration of blood pressure meds, carpal tunnel syndrome & rheumatoid arthritis , & FDA approval of finerenone for HFpEF. Fill your brain hole with a ... Show More
58m 49s
Aug 18
#495 Fungal Infections -Histo/Blasto/Cocci with Dr. Andrej Spec
Why we need to stop calling them “endemic” mycoses & more fungi fun! Feeling muddled about endemic mycoses? We tackle the clinical presentation of diseases like histoplasmosis, blastomycosis, and coccidioidomycosis, the importance of testing, and how to diagnose fungal infections ... Show More
1h 12m
Aug 11
#494 C. diff, Diarrhea, the Microbiome, and New Therapies with Dr. Cynthia Sears. Live from Johns Hopkins Grand Rounds
Dominate C. diff! Learn to distinguish colonization from infection, select first-line therapies, and counsel patients on recurrence prevention and microbiome recovery. We’re joined by IDSA past president and expert on foodborne and intestinal infections, Dr. Cindy Sears (Johns Ho ... Show More
57m 50s
Mar 2023
Say "Hi" to the #NephMadness PodCrawl
Welcome to the NephMadness PodCrawlThe idea behind a podcrawl is for a variety of podcasts to coordinate on timing and topic to push a theme and get each other’s listeners to explore all of the podcasts. One of the first goals behind NephMadness was to build a community and in th ... Show More
1m 16s
Mar 2023
Freely Filtered 057: NephMadness 2023 TMA
The Filtrate:Joel TopfSwapnil HiremathJosh WaitzmanSophia AmbrusoWith Special Guest:Anna Vinakova Associate Professor of Medicine at Virginia Commonwealth University. NephMadness Executive. Vanuja Java is a transplant nephrologist at Washington University in St. Louis, MO. Her re ... Show More
1h 21m
Mar 2024
85 - NephMadness 2024
Welcome to NephMadness 2024! In collaboration with Things We Do For No Reason (TWDFNR), we are excited to promote the start of this amazing medical education opportunity. Inspired by the "March Madness" college basketball tournament, NephMadness is a "a free online, CME-granting, ... Show More
28m 59s
Jun 2024
Episode 72: Nefecon for IgAN, The NefIgArd part B trial
The Filtrate:Joel TopfJosh WaitzmanWith Special Guest:Brad Rovin (@BradRovin) Chief of nephrology at The Ohio State University Wexner Medical Center, one of the authors of the Nefigard trial. Koyal Jain (@koyaljainMD) Program director of the GN Fellowship at University of North C ... Show More
1h 32m
Jun 2024
Jun 14 2024 This Week in Cardiology
Listener feedback, statin eligibility and Yogi Berra, evidence-based medicine and heterogenous treatment effects, and MRAs in HF are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial trans ... Show More
30m 52s
Jun 2024
What’s Inside Your Coronary Arteries? with Anita Vadria, MS, PA-C (Episode 182)
Menopause and age raise our cardiovascular disease risk. Athletes and highly active people also tend to have a higher prevalence of coronary artery calcium and atherosclerotic plaque (though it tends to be the benign kind). But what does that all mean? How can we know what’s real ... Show More
45m 31s
Jun 2024
Episode 340: Rafael Medina Subspecialty Series – Headache & Blurry vision
https://clinicalproblemsolving.com/wp-content/uploads/2024/06/Nephro-VMR-June24-final.mp3In this Nephrology Rafael Medina Subspecialty episode, Dr. Maddie Abrams presents a case to Dr. Jai Radhakrishnan of a 28 year old woman presenting with headache and blurry vision.Session fa ... Show More
58m 20s
Oct 2023
Episode 11: Goosebumps & Kidney Week 2023
In Episode 11, guests Jordy Cohen & Samir Parikh (and members of the American Society of Nephrology Kidney Week Education Committee) join us for a discussion about Kidney Week 2023 and their careers as physician-scientists. They discuss their journeys to their current careers, wh ... Show More
30m 33s
Apr 2024
Episode 69:DUPLEX Sparsentan, it’s no Acthar Gel
The Filtrate:Joel TopfSwapnil HiremathPriya Yenebere Nayan AroraWith Special Guest:Brendon Neuen Super smart guy and clinical trialistMichelle Rheault Lead author of DUPLEX and friend of the podShow NotesSparsentan versus Irbesartan in Focal Segmental GlomerulosclerosisNephJC Sum ... Show More
1h 41m